Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, has received MHRA marketing authorisation
Ongoing care runs through portal messaging, which is available 24/7 for nonurgent questions
Learn More About Our Medical Weight Loss Effective Weight Loss Alternatives Though it is common to experience weight gain after stopping Ozempic, Wegovy, Mounjaro and Zepbound, several alternatives can help patients lose and keep it off longer term
Some state boards adopted near-verbatim language, proposing burdensome documentation requirements or strict adherence to branded drug dosageseven when prescribed differently by licensed physicians
Mounjaro slows down how quickly food leaves your stomach
Educated decisions and transparent discussions with medical professionals are critical for anyone thinking about retatrutide therapy
